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Abstract—Porphyromonas gingivalis is an oral pathogen highly implicated in chronic periodontitis,
a disease characterized by inﬂammatory destruction of the tooth-supporting alveolar bone and
eventually, tooth loss. T-cell innate immune responses are actively involved in this pathological
process. Receptor activator of NF-κB Ligand (RANKL) is a cytokine that stimulates bone resorp-
tion, while its soluble decoy receptor osteoprotegerin (OPG) blocks its action. This study aimed to
investigate in Jurkat T-cells the effects of P. gingivalis on the RANKL-OPG system and the major
inﬂammatory mediator of bone resorption prostaglandin E2 (PGE2). P. gingivalis caused
concentration-dependent up-regulation of RANKL gene expression and protein production,
assessed by quantitative PCR and ELISA, respectively. PGE2 production was also enhanced.
However, OPG was not detected. In conclusion, P. gingivalis induces RANKL and PGE2 in
T-cells, potentially favoring bone resorption. These T-cell responses to P. gingivalis may
contribute to the pathogenesis of inﬂammatory alveolar bone destruction occurring in chr-
onic periodontitis.
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INTRODUCTION
Periodontal disease is potentially the most common
inﬂammatory disease of infectious etiology in humans. It
is characterized by the destruction of the tooth-support-
ing (periodontal) tissues, ultimately resulting in tooth
loss. Porphyromonas gingivalis is a Gram-negative
black-pigmenting anaerobe, highly implicated in human
chronic periodontitis [1]. In vivo studies have also
demonstrated that P. gingivalis can induce periodontitis
in experimental animal models [2]. It is postulated that
this oral pathogen can perturb the local immunity and
deregulate the host inﬂammatory responses in the
periodontal tissues, properties attributed to its virulence
factors [3–5]. Due to these properties, P. gingivalis may
invade into the deeper periodontal tissues [6] and
establish chronic inﬂammation.
The pathogenesis of periodontitis involves the
destruction of the tooth-supporting alveolar bone as a
result of the inﬂammation triggered by oral bacteria.
Early observations have outlined that the presence of
lymphocytes in the inﬂammatory inﬁltrate of histopatho-
logical lesions of periodontitis [7]. It is now well
established that T-cells, have a key role in the patho-
genesis of periodontal disease, particularly by mediating
the resorption of the alveolar bone [8, 9]. The notion that
CD4+ Th1 cells are central to the cell-mediated
immunity events associated with the disease, particularly
through interferon-γ production, is now challenged by
the discovery of the interleukin-17-producing Th17
population [10]. Although it has been proposed that
Th17 cells confer speciﬁc osteoclast-inducing activity
[11], their precise role in periodontitis is still unclear. On
the molecular level, the process of bone resorption is
determined by the interplay of members of the tumor
necrosis factor (TNF) ligand and receptor families [12].
Receptor activator of NF-κB ligand (RANKL), a
member of the TNF ligand family, is expressed as cell
surface-associated or secreted ligand by osteoblasts,
periodontal ﬁbroblasts, as well as activated T- and B-
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cells [13]. RANKL expression can be induced by several
systemic hormones and local inﬂammatory mediators,
such as prostaglandin E2 (PGE2) [14]. RANKL activates
its cognate receptor activator of NF-κB (RANK)
receptor on monocytic precursors, triggering their differ-
entiation into multinucleated bone-resorbing osteoclasts.
Osteoprotegerin (OPG) is a soluble decoy receptor for
RANKL that inhibits its interaction with RANK, thus
preventing osteoclastogenesis and bone resorption [15].
The importance of these molecules in periodontal
diseases has been demonstrated in clinical investigations
[16, 17].
Recent work has demonstrated that P. gingivalis
up-regulates RANKL and down-regulates OPG expres-
sion in gingival ﬁbroblasts and periodontal ligament
cells [18], as well as bone marrow stromal cells [19].
PGE2 is considered a potential mediator of P. gingivalis-
induced RANKL expression [19–21]. It is also well
established that P. gingivalis is a potent inducer of T-cell
responses [22, 23]. These responses appear to mediate
alveolar bone loss in related experimental periodontitis
model [24, 25]. However, there is as yet no evidence on
the potential effects of P. gingivalis on the regulation of
the RANKL-OPG system in T-cells. This information
would provide additional mechanistic insights to the role
of P. gingivalis in bone resorption occurring in periodontitis.
Therefore, the aim of this study was to investigate the effect
of P. gingivalis on RANKL and OPG gene expression and
protein secretion, as well as PGE2 production, in a human T-
cell line.
MATERIALS AND METHODS
Cell Cultures
Jurkat T-lymphocyte leukemia cells (E6-1; Ameri-
can Type Tissue Culture Collection) were used in this
study. The cells were maintained in RPMI Glutamax
(Gibco BRL Life Technologies) supplemented with 10%
fetal bovine serum. The cells were cultured in suspen-
sion at a density of 106 cells/ml. For the experiments, the
cells were cultured in the presence or absence of
ascending protein concentrations of P. gingivalis
culture supernatants for 6 h.
Bacterial Cultures and Growth Conditions
P. gingivalis W50 wild-type strain was cultured on
blood agar base supplemented with 5% horse blood
(Oxoid) and maintained by weekly subculture for up to
5 weeks. Liquid cultures were prepared by inoculation of
bacterial colonies (3-4 days old) from blood agar plates
into 10 ml brain heart infusion broth (Oxoid) supple-
mented with 5 mg/l hemin (Sigma), and incubated for
24 h. Ten percent inoculum was transferred to 90 ml of
the same medium and incubated for 6 days. All cultures
were grown at 37°C in a Don Whitley anaerobic cabinet,
MACS MG500, in an atmosphere of 80% N2, 10% H2,
and 10% CO2. After this culture period, bacteria were
harvested by centrifugation at 10,000×g for 15 min at
4°C and supernatants were collected, ﬁlter-sterilized
over a 0.2 μm ﬁlter, and stored at −80°C until use.
Protein concentration of these P. gingivalis preparations
was determined by Bio-Rad Protein assay (Bio-Rad).
For the experiments, these culture supernatants were
diluted in the cell culture medium. Their ﬁnal concen-
tration in the experimental cell cultures was expressed in
microgram per milliliter.
Extraction of Total RNA and Synthesis of cDNA
Upon termination of the experiments, total RNA
was extracted from the cells using RNeasy Mini kit
(QIAGEN) according to the manufacturer’s instructions.
RNA was quantiﬁed using a nanodrop spectrophotrom-
eter and reversed transcribed into cDNA. One micro-
gram of total RNA was incubated with 0.5 µg/ml of
oligo dT primer (Promega) at 70°C for 5 min and cooled
on ice. A master mix was added to samples, comprising
of 10 mM dNTPs, 200 units of moloney murine
leukemia virus reverse-transcriptase enzyme and buffer
(Promega), and dH20 to a ﬁnal volume of 25 μl. For the
reverse-transcription reaction, these samples were incu-
bated at 40°C for 60 min, 70°C for 15 min and cooled
down to 4°C.
Quantitative Real-time Polymerase Chain Reaction
(qPCR)
The quantiﬁcation of RANKL and OPG mRNA
expression was performed by TaqMan® qPCR analysis
using an ABI Prism 7900 HT Sequence Detection
System and software (Applied Biosystems). For the
ampliﬁcation reactions, a qPCR master mix was used
(Abgene). The ampliﬁcation conditions were 10 min at
95°C, followed by 40 cycles at 95°C for 15 s and 60°C
for 1 min. The Gene Expression Assay (Applied
Biosystems) IDs were: RANKL: Hs00243522-m1,
OPG: Hs00171068-m1, GAPDH: Hs99999905-m1, and
ubiquitin C (UBC): Hs01871556-m1. The relative
expression levels of RANKL and OPG transcripts were
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calculated by using the comparative ΔCt method (2−ΔCt
formula), after normalization to the average Ct values of
housekeeping genes UBC and GAPDH.
Quantiﬁcation of RANKL, OPG and PGE2 Levels
by Enzyme-linked Immunosorbent Assay (ELISA)
Upon termination of the experiments, the Jurkat T-
cell cultures in suspension were centrifuged at 1,000 rpm
for 5 min. The resulting supernatants were collected for
further analysis. Commercially available human-speciﬁc
ELISA kits were used to quantify RANKL (Immun-
diagnostik), OPG (Biomedica), and PGE2 (Parameter,
R&D Systems) in these culture supernatants.
Statistical Analysis
The signiﬁcance of differences between control and
test groups was assessed by one-way analysis of
variance, and Bonferroni post hoc test. P values <0.05
were considered indicative of statistical signiﬁcance.
RESULTS
Jurkat T-cells were challenged with ascending
protein concentrations of P. gingivalis. Concentrations
equal or lower than 6.4 μg/ml were used, as these did
not elicit any cytotoxic effects as previously determined
[26]. The effect on RANKL regulation was ﬁrst
investigated. The qPCR results indicate that P. gingivalis
caused a concentration-dependent up-regulation of
RANKL mRNA expression after a 6-h challenge period
(Fig. 1). The highest P. gingivalis concentration (6.4 µg/
ml) caused a 3.7-fold up-regulation of RANKL mRNA
expression, compared to the control. Further on, ELISA
analysis revealed that RANKL protein secretion was
concomitantly increased in the cell culture supernatants,
in a concentration-dependent manner (Fig. 2). Compared
to the control, RANKL protein levels were increased by
2.2-fold with the highest P. gingivalis concentration
used.
The effect of P. gingivalis on the regulation of
OPG, the inhibitor of RANKL, was also investigated in
the present experimental systems. However, neither
OPG mRNA expression, nor OPG protein secretion
were detected in the cell cultures under these conditions,
irrespective of the presence or absence of P. gingivalis
challenge.
Finally, the effect of P. gingivalis on PGE2
production was also investigated. The secreted PGE2
levels in the cell culture supernatants were measured by
ELISA. After 6 h of challenge, P. gingivalis enhanced
PGE2 secretion in a concentration-dependent manner
(Fig. 3). The highest concentration of P. gingivalis used
caused a 2.1-fold up-regulation, compared to the control.
Fig. 1. Effect of P. gingivalis on RANKL mRNA expression in Jurkat
T-cells. The cells were challenged with ascending protein concentra-
tions of P. gingivalis culture supernatants for 6 h. The mRNA expres-
sion levels of RANKL were measured by quantitative real-time PCR
normalized against the expression levels of the housekeeping genes.
The results are expressed as the 2−ΔCt formula. Bars mean values±
SEM from three independent experiments; asterisk statistically
signiﬁcant difference compared to the control group.
Fig. 2. Effect of P. gingivalis on RANKL protein secretion by Jurkat
T-cells. The cells were challenged with ascending protein concentra-
tions of P. gingivalis culture supernatants for 6 h. The concentrations of
RANKL protein secreted into the culture supernatants were quantiﬁed
by ELISA. The results are expressed as concentration detected in the
cell culture supernatant (picogram per milliliter). Bars mean values±
SEM from three independent experiments: asterisk statistically signiﬁ-
cant differences compared to the control group.
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DISCUSSION
The present in vitro study has investigated the
effect of P. gingivalis on the regulation of the RANKL-
OPG system in the Jurkat T-cells. The results indicate
that P. gingivalis induces RANKL gene expression, with
concomitant RANKL protein production by T-cells. This
is in line with previous studies demonstrating that P.
gingivalis induces RANKL expression in gingival and
periodontal ligament ﬁbroblasts [18], as well as bone
marrow stromal cells [19]. Therefore, the present ﬁnding
conﬁrms that T-cells are also responsive to P. gingivalis
in terms of RANKL induction, among other cell types.
Although in this experimental system the magnitude of
RANKL induction appears to be modest, this osteo-
immunologic response is not trivial. It is an important
addition to the current knowledge on the mechanisms of
pathogenesis of periodontitis as it may provide a
molecular insight to the T-cell mediated responses of P.
gingivalis in alveolar bone resorption [24]. It is also
interesting to note that Jurkat T-cells produce TNF-α-
converting enzyme (TACE) in response to P. gingivalis
challenge [26]. TACE is a metalloprotease able to shed
RANKL from the cell membrane surface, thus facilitating
its release into the immediate extracellular environment
and propagating its action [27].
The regulation of OPG was also investigated in the
present experimental system. However, OPG expression
was not detected in these cells and P. gingivalis
challenge was not able to induce its expression. The
lack of capacity by Jurkat T-cells to express OPG even
in response bacterial challenge has previously been
demonstrated [28], although it has also been reported
that normal CD4+ T-cells can produce OPG [29]. This is
an interesting point, as T-cell inﬁltrates in active
periodontal lesions could stimulate bone resorption via
RANKL, but it is not clear if they would be able to
restore the physiological balance by compensatory OPG
production that would inhibit osteoclastogenesis. This
could potentially be contributed by the resident perio-
dontal connective tissue cells.
It is known that PGE2 has a major role in the
regulation of bone resorption [30], with strong implica-
tion in periodontitis [31, 32]. One of the main
mechanisms by which PGE2 is involved in bone
resorption is by triggering RANKL expression by a
variety of cells, and therefore activating the downstream
events that lead to osteoclast formation and activation
[14]. Among other cells, Jurkat T-cells are also known to
produce PGE2 [33–35]. It has been shown that P.
gingivalis can induce PGE2 production in a variety of
cell types, including gingival ﬁbroblasts [36], epithelial
cells, and macrophages [37], osteoblasts [20], bone
marrow stromal cells [19], as well as whole blood cells
[38]. The present study demonstrates that P. gingivalis
enhances PGE2 production in Jurkat T-cells as well,
concomitantly to RANKL. This corroborates previous
studies showing that PGE2 is a potential mediator of
RANKL induction by P. gingivalis [19–21], although
this remains to be proven in the present experimental
system as well.
In conclusion, the present study demonstrates that
P. gingivalis induces RANKL, but not OPG expression
in Jurkat T-cells. The production of the key inﬂamma-
tory mediator of bone resorption PGE2 is also enhanced
in this experimental system. This indicates that P.
gingivalis regulates T-cell function in a manner that
favors osteoclastogenesis and bone resorption. These
observations provide a further mechanistic insight on the
role of T-cells in the pathogenesis of periodontal disease,
particularly in forms that P. gingivalis is involved, such
as chronic periodontitis.
Periodontal connective tissue cells and T-cells
appear to exhibit differential RANKL and OPG expres-
sions. The former are resident cells that constitutively
express OPG, but not RANKL, unless they are bacte-
Fig. 3. Effect of P. gingivalis on PGE2 production by Jurkat T-cells.
The cells were challenged with ascending protein concentrations of P.
gingivalis culture supernatants for 6 h. The concentrations of PGE2
secreted into the culture supernatants were quantiﬁed by ELISA. The
results are expressed as concentration detected in the culture super-
natant (picogram per milliliter). Bars mean values±SEM from three
independent experiments; asterisk statistically signiﬁcant differences
compared to the control group.
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rially challenged [18]. This denotes a role in maintaining
periodontal homeostasis, but also in contributing to
periodontal pathogenesis. On the contrary, T-cells are
found in restricted numbers in the healthy periodontium,
but are abundant in the disease. Therefore, enhanced
RANKL expression by these cells when present in the
periodontium may be detrimental for the development of
periodontitis.
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